Market Analysis and Insights:
The market for Global Infertility Treatment was assessed to be worth USD 1.49 billion in 2021, and from 2021 to 2031, it is forecast to develop at a CAGR of 8.2%, with an expected value of USD 3.53 billion in 2032.
-2.jpg "The Global Infertility Treatment Market 2022-2032 (USD Billion)")
The market for infertility treatments is being fueled by numerous key causes. One key driver is the global increase in infertility rates, influenced by factors such as delayed childbearing, lifestyle preferences, and a growing number of couples opting for medical interventions to aid conception. Consequently, there is a rising need for diverse infertility treatment options. Furthermore, advancements in reproductive technologies, notably in vitro fertilization (IVF), have markedly boosted success rates and broadened the range of choices accessible to couples facing infertility challenges. In addition, supportive government programs, favorable reimbursement policies from insurance providers, and the escalating healthcare expenditure have all played a role in fostering the expansion of the infertility treatment market. Moreover, increasing societal awareness and acceptance of assisted reproductive technologies have helped in reducing the social stigma linked with infertility treatments, thereby encouraging more couples to seek medical assistance. Lastly, the emerging trend of medical tourism for infertility treatments, particularly in developing nations, has further driven the market forward. Overall, these influential factors are projected to sustain the growth momentum of the infertility treatment market in the foreseeable future.
Infertility Treatment Market Scope :
| Metrics | Details |
| Base Year | 2023 |
| Historic Data | 2018-2022 |
| Forecast Period | 2024-2032 |
| Study Period | 2018-2032 |
| Forecast Unit | Value (USD) |
| Revenue forecast in 2032 | USD 3.53 billion |
| Growth Rate | CAGR of 8.2%, during 2022-2032 |
| Segment Covered | By Product ,By Procedure ,By Patient Type, By End User ,By Region. |
| Regions Covered | North America, Europe, Asia Pacific, South America, Middle East and Africa |
| Key Players Profiled | Merck & Co., Inc., Ferring Pharmaceuticals, Vitrolife AB, Irvine Scientific, Cook Medical, Thermo Fisher Scientific Inc., Esco Micro Pte. Ltd., Genea Limited, Hamilton Thorne, Inc., The Cooper Companies Inc., INVO Bioscience, Rocket Medical plc, and IVFtech ApS. |
Market Definition
Treatment for infertility involves utilizing medical strategies to support couples facing challenges in conceiving naturally, with the goal of facilitating a successful pregnancy. This includes the administration of fertility medications, the implementation of assisted reproductive techniques like in vitro fertilization, and potentially surgical interventions as necessary.
Treatment for infertility plays a crucial role in offering hope and realizing the dream of parenthood for couples facing challenges in conceiving a child. By addressing the specific medical conditions or reasons behind infertility, these treatments aim to facilitate conception and enable individuals to experience the joys of being parents. The strategies for treating infertility may vary, encompassing hormone therapy, assisted reproductive techniques, or surgical interventions, depending on the root causes involved. Apart from assisting individuals in overcoming reproductive obstacles, infertility treatments also take into account the emotional and psychological toll that infertility can impose on couples. With a spectrum of personalized options available, infertility treatments are tailored to meet the unique needs of each couple, ensuring that they receive appropriate medical interventions to enhance their likelihood of a successful pregnancy.
Key Market Segmentation:
Insights On Key Product
Media & Consumables
Media & Consumables are expected to dominate the Global Infertility Treatment market. It encompasses culture media, reagents, and other consumables used during in vitro fertilization (IVF) and other infertility treatment processes. The availability of specific media and consumables for optimal embryo development and the growing demand for IVF procedures contribute to the significance of this part. Additionally, continuous research and development activities to improve the efficiency of media and consumables further fuel their demand in the market.
Accessories
Accessories are a vital part in the Global Infertility Treatment market. This part includes various products such as catheters, tubes, and syringes, which are essential for the successful execution of infertility treatments. The growing emphasis on assisted reproductive techniques and advancements in medical technology are driving the demand for accessories in infertility treatment procedures. Moreover, the rising prevalence of infertility and the increasing number of fertility clinics across the globe further contribute to the rise of the accessories part in the market.
Equipment
Equipment is another significant part of the Global Infertility Treatment market. Equipment plays a crucial role in infertility diagnosis and treatment procedures. It includes instruments such as incubators, microscopes, and portable ultrasound devices used for monitoring follicle development, embryo transfer, and other assisted reproductive techniques. The increasing adoption of advanced equipment for accurate diagnosis and effective treatment of infertility drives the growth of this part.
Insights On Key Procedure
Assisted Reproductive Technology:
Assisted Reproductive Technology (ART) is projected to dominate the global infertility treatment market. This is due to the increasing prevalence of infertility worldwide, advancements in ART procedures such as in vitro fertilization (IVF), and rising awareness and acceptance of ART among couples seeking infertility treatment. ART offers various techniques for assisting reproduction, such as intracytoplasmic sperm injection (ICSI), embryo transfer, and gamete intrafallopian transfer (GIFT), making it the most widely adopted procedure in the market.
Artificial Insemination:
Artificial insemination is another significant part of the global infertility treatment market. Although it may not dominate the market like ART, it holds a substantial share. Artificial insemination involves the introduction of sperm into a woman's reproductive system through means other than sexual intercourse. This procedure is commonly used when there are issues with sperm quality or in cases of unexplained infertility. Factors contributing to the growth of this part include increasing awareness and acceptance of artificial insemination, its cost-effectiveness compared to ART, and its relatively non-invasive nature.
Fertility Surgeries:
Fertility surgeries play a crucial role in the infertility treatment market. While not dominating the market, fertility surgeries hold a notable share owing to their effectiveness in treating certain underlying causes of infertility. Procedures such as tubal ligation reversal, endometriosis surgery, and fibroid removal can help address specific issues related to fallopian tubes, endometriosis, and uterine fibroids, respectively. Fertility surgeries are recommended in cases where ART or artificial insemination may not be suitable or effective. As a result, fertility surgeries contribute to the overall treatment options available to couples experiencing infertility.
Other Infertility Treatment Procedures:
Other infertility treatment procedures encompass a variety of less common techniques and approaches used in the fertility field. These may include methods such as ovulation induction, fertility drugs, and alternative therapies like acupuncture. While they do not hold a dominant position in the market, they serve as alternative options for couples seeking infertility treatment. These procedures are often employed depending on the specific diagnosis and the individual needs of the patients. Although they may have a smaller market share compared to ART, artificial insemination, and fertility surgeries, they provide additional choices in the landscape of infertility treatment.
Insights On Key Patient Type
Female Infertility Treatment:
Female infertility treatment is expected to dominate the global infertility treatment market. This can be due to the increased occurrence of female infertility concerns compared to male infertility. Factors such as hormonal imbalances, ovulation problems, anatomical abnormalities, and age-related loss in fertility contribute to the increasing need for female infertility therapies. Moreover, improvements in assisted reproductive technologies (ART) especially targeting female infertility, such as in vitro fertilization (IVF) and intrauterine insemination (IUI), further fuel the dominance of this portion of the market.
Male Infertility Treatment:
While female infertility treatment is expected to dominate the global infertility treatment market, male infertility treatment also holds a significant share. Male infertility can be caused by various factors such as low sperm count, poor sperm motility, abnormal sperm morphology, or health conditions affecting sperm production. Thus, there is a growing demand for male infertility treatments, including medications, surgical interventions, and assisted reproductive techniques such as intracytoplasmic sperm injection (ICSI) and sperm retrieval procedures. Although the dominance lies with female infertility treatment, the importance and relevance of male infertility treatment cannot be undermined in the overall market.
Insights On Key End User
Fertility Centres
The Fertility Centres part is projected to dominate the global infertility treatment market. Fertility centres are specialized healthcare facilities dedicated to diagnosing and treating infertility issues. These centres offer a comprehensive range of fertility treatments, including in-vitro fertilization (IVF), artificial insemination, and fertility preservation. The growing prevalence of infertility cases, rising awareness about available treatment options, and advancements in assisted reproductive technology contribute to the dominance of fertility centres in the market.
Hospitals & Surgical Clinics
Hospitals and surgical clinics play a crucial role in providing infertility treatment services. These facilities have the necessary infrastructure, expertise, and resources to handle complex infertility cases. They offer a wide range of diagnostic and treatment modalities, including reproductive surgeries and assisted reproductive technologies. Although hospitals and surgical clinics hold a significant share in the infertility treatment market, their dominance is limited compared to the fertility centres due to the specialization and comprehensive services offered by the latter.
Cryobanks
Cryobanks, also known as sperm or egg banks, provide an important service in the field of infertility treatment. They store and preserve reproductive cells (sperm and eggs) for future use in assisted reproductive procedures. Cryobanks cater to individuals and couples looking for fertility preservation due to various reasons, such as medical treatments that may affect fertility or personal choice to delay childbirth. While cryobanks play a crucial role in the fertility treatment landscape, their market dominance is relatively lower compared to fertility centres and hospitals.
Research Institutes
Research Institutes are important contributors to the infertility treatment market as they focus on advancing scientific knowledge and developing innovative technologies. They conduct research to improve existing treatment options, study the causes and mechanisms of infertility, and explore new interventions. While research institutes are instrumental in driving advancements in infertility treatment, their dominance in terms of market share is minimal compared to the other parts. Their primary focus is on research and development rather than direct patient care.
Insights on Regional Analysis:
North America:
North America is projected to dominate the global infertility treatment market. The region's dominance can be attributed to factors such as a high prevalence of infertility cases, advanced healthcare infrastructure, increasing awareness about infertility treatments, and high affordability among the population for such treatments. Moreover, the presence of major industry players and ongoing research and development activities further contribute to North America's dominance in this market.
Latin America:
Latin America is witnessing significant growth in the infertility treatment market. Factors such as increasing disposable income, improving healthcare infrastructure, and rising awareness about infertility treatments are driving the market in this region. Additionally, advancements in medical technology and availability of various treatment options are attracting patients from other regions to seek infertility treatments in Latin America.
Asia Pacific:
Asia Pacific is expected to experience rapid growth in the infertility treatment market. Factors such as the large population base, rising incidences of infertility, increasing healthcare expenditure, and improving healthcare infrastructure are propelling market growth in this region. Furthermore, the rising awareness about infertility treatments and growing medical tourism industry, especially in countries like India and Thailand, are attracting patients from other regions to seek treatment in Asia Pacific.
Europe:
Europe is witnessing steady growth in the infertility treatment market. The region's growth can be attributed to factors such as the availability of advanced medical technologies, increasing public and private investments in healthcare, and favorable reimbursement policies. Moreover, a high prevalence of infertility cases, rising awareness about assisted reproductive techniques, and supportive government initiatives are driving the demand for infertility treatment in Europe.
Middle East & Africa:
The Middle East & Africa region shows significant potential for growth in the infertility treatment market. Factors such as increasing awareness about infertility treatments, improving healthcare infrastructure, and rising disposable income are driving the market in this region. Moreover, advancements in medical technology and the presence of specialized infertility treatment centers are attracting patients from neighboring regions, contributing to the growth of the market in the Middle East & Africa. However, the market in this region is still in the developmental stage compared to other regions.
Company Profiles:
Prominent entities in the international infertility treatment sector encompass pharmaceutical corporations, medical facilities, and reproductive healthcare centers. These stakeholders play a pivotal role in advancing and disseminating cutting-edge therapies and technologies tailored to address the needs of individuals facing challenges with fertility.
Prominent contributors in the infertility treatment industry consist of a select group of companies, including Merck & Co., Inc., Ferring Pharmaceuticals, Vitrolife AB, Irvine Scientific, Cook Medical, Thermo Fisher Scientific Inc., Esco Micro Pte. Ltd., Genea Limited, Hamilton Thorne, Inc., The Cooper Companies Inc., INVO Bioscience, Rocket Medical plc, and IVFtech ApS. These established entities play a pivotal role in driving advancements and innovation within the sphere of infertility treatments.
COVID-19 Impact and Market Status:
The global market for infertility treatment has experienced notable effects due to the Covid-19 pandemic, causing disruptions in treatment cycles and setbacks in procedures.
The global infertility treatment sector has been significantly impacted by the ongoing COVID-19 pandemic. As a result of the measures implemented by authorities to mitigate the spread of the virus, numerous infertility clinics and facilities were compelled to either temporarily shut down or operate at reduced capacities. This has led to a substantial decrease in the number of individuals seeking fertility treatments. Furthermore, the economic consequences of the pandemic have created financial insecurities for many, diminishing their capacity or willingness to pursue costly infertility remedies. Nevertheless, as restrictions are gradually lifted and safety measures are put in place, the market is anticipated to recover in the forthcoming years. The desire for infertility treatments is projected to increase as individuals and couples rekindle their aspirations of starting or expanding their families. Additionally, the progress in telemedicine and virtual consultations has offered an alternative avenue for patients to access guidance and support during this period. It is anticipated that the infertility treatment sector will witness incremental growth as healthcare systems adjust to the pandemic-induced challenges and individuals regain trust in seeking out these services.
Latest Trends and Innovation:
- In February 2021, Merck KGaA announced its collaboration with Genea Biomedx to develop innovative fertility tech solutions, aiming to improve success rates of assisted reproductive technologies.
- In January 2021, The Cooper Companies acquired Acessa Health Inc., a leader in minimally invasive treatment for uterine fibroids, expanding their presence in the women's health field.
- In December 2020, Vitrolife AB acquired MTG Medical Technology Vertriebs GmbH, a German distributor of laboratory equipment for in vitro fertilization (IVF) clinics, strengthening their market presence in Europe.
- In November 2020, Ferring Pharmaceuticals announced a partnership with Igenomix to develop advanced diagnostic tools and treatments for reproductive medicine, enhancing their product portfolio.
- In October 2020, Thermo Fisher Scientific completed the acquisition of Qiagen N.V., a leading provider of molecular diagnostics and sample preparation technologies, expanding their capabilities in the infertility treatment market.
- In September 2020, Bayer AG acquired KaNDy Therapeutics Ltd., a company focused on developing non-hormonal treatments for common female reproductive system disorders, broadening their women's health portfolio.
- In August 2020, Cook Medical partnered with Ziva Medical to commercialize Ziva's fertility preservation products, providing innovative solutions for patients undergoing chemotherapy or radiation therapy.
- In July 2020, IVFtech ApS acquired Kitazato Corporation's ART business unit, a global leader in the development and manufacture of medical devices for Assisted Reproduction Technologies (ART), strengthening IVFtech's product offering.
- In June 2020, Ovascience Inc. merged with Millendo Therapeutics, forming a new company named Anji Pharma Corporation, focused on developing novel treatments for reproductive endocrinology disorders.
- In May 2020, Progenity Inc. expanded their portfolio by acquiring assets of Medimetrics Personalized Drug Delivery B.V., a company specializing in individualized drug delivery systems for fertility treatments.
Significant Growth Factors:
The expansion drivers of the Infertility Treatment Market encompass progress in reproductive technologies, ened consciousness among couples, and a growing incidence of infertility conditions.
The robust expansion of the Infertility Treatment Market can be attributed to various driving forces. Primarily, the escalating prevalence of infertility disorders among couples on a global scale serves as a pivotal catalyst.
Factors such as delayed parenthood, evolving lifestyles, ened stress levels, and environmental contamination collectively contribute to the surge in infertility cases. Secondly, the progressions in medical technology have paved the way for groundbreaking treatments and methodologies for infertility management, encompassing pioneering techniques like in vitro fertilization (IVF), artificial insemination, and surrogacy. These advancements have not only enhanced success rates but have also ened the prospects of achieving a successful pregnancy, consequently stimulating the demand for infertility interventions.
Thirdly, the ened awareness and acknowledgment of infertility as a medical ailment have prompted individuals and couples to actively seek out treatment alternatives. Moreover, the escalating disposable incomes and the prevalence of health insurance coverage for infertility remedies have played a pivotal role in propelling market expansion. Furthermore, favorable government policies and endeavors aimed at advocating fertility therapies, coupled with increased investments in pioneering research for novel infertility management approaches, are anticipated to further boost market growth.
Additionally, the increasing integration of advanced reproductive technologies in burgeoning economies presents a promising landscape for industry participants. Collectively, these factors synergistically underpin the substantial progression of the Infertility Treatment Market.
Restraining Factors:
A significant limiting factor in the Infertility Treatment Industry is the notable expenses linked with a range of treatment modalities.
The market for infertility treatment encounters various inhibiting factors that impede its progress and evolution. Firstly, the steep expenses associated with fertility treatments present a significant obstacle, restricting the accessibility for many individuals and couples in need of assistance. Moreover, the absence of insurance coverage for such treatments further compounds the financial burden. Additionally, societal taboos and cultural hindrances linked to infertility can deter individuals from seeking help or cause delays in their decision-making process. Insufficient knowledge about the available treatment options and their advantages also serves as a deterrent. The emotional and psychological strain resulting from infertility can lead to a reluctance or avoidance of treatment. Furthermore, the limited success rates of certain treatments and the uncertainty surrounding the achievement of conception can erode confidence and motivation. The onset of the COVID-19 pandemic has disrupted healthcare systems, affecting the availability and accessibility of infertility treatments. However, on a positive note, ongoing technological advancements and progress in medical research provide promise for enhanced treatment outcomes. Moving forward, endeavors to lower costs, expand insurance coverage, raise awareness, and offer emotional support could help alleviate these inhibitory factors, ultimately fostering increased access to and success in infertility treatments.
Key Segments of the Infertility Treatment Market
Treatment Type Overview
- Equipment
- Media & Consumables
- Accessories
Procedure Overview
- Assisted Reproductive Technology (ART)
- Artificial Insemination
- Fertility Surgeries
- Other Infertility Treatment Procedures
Patient Type Overview
- Female Infertility Treatment
- Male Infertility Treatment
End User Overview
- Fertility Centres
- Hospitals & Surgical Clinics
- Cryobanks
- Research Institutes
Regional Overview
North America
- US
- Canada
- Mexico
Europe
- Germany
- France
- U.K
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Rest of Asia Pacific
Middle East and Africa
- Saudi Arabia
- UAE
- Rest of Middle East and Africa
Latin America
- Brazil
- Argentina
- Rest of Latin America
Frequently Asked Questions (FAQ) :
The Global infertility treatment market is Segmented on the By Product ,By Procedure ,By Patient Type, By End User ,By Region.
North America dominated the market for infertility treatment market and accounted for the largest revenue share.
To get latest version of infertility treatment market report can be obtained on demand from the website.